Delivery Order SPE2DB22D3019-SPE2DB25FK3XE
- Not listed
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $2,753.70 and a period of performance through July 2, 2025. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a...
- This is a delivery order contract awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the supply of the drug WEGOVY 1 MG/0.5 ML PEN 0.5ML. The contract has a firm-fixed price, a ceiling value of $1,353.56, and a completion date of June 12, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00, which serves as a comprehensive global...
- This is a federal Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,661.55, is for the supply of the drug WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a firm fixed price and a period of performance through November 13, 2024. The contract was not set aside for any specific business type. AmerisourceBergen Drug Corp holds a significant...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $9,972.88 firm-fixed-price delivery order is for the supply of the medication WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a period of performance through May 27, 2025 and is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a firm fixed price of $3,996.26 and a period of performance through June 4, 2025. AmerisourceBergen Drug Corp holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which enables the company to provide a wide range of pharmaceutical...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of the prescription medication WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, with a ceiling value of $5,414.50 and a period of performance through May 23, 2025. The contract is a firm fixed-price, non-set-aside agreement, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
- This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of the medication WEGOVY 2.4 MG/0.75 ML PEN 0.75ML, with a ceiling value of $15,537.11. The contract is a firm fixed-price, non-set-aside contract with a completion date of July 16, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication WEGOVY 1.7 MG/0.75 ML PEN 0.75ML. The contract has a firm fixed-price, non-set-aside pricing structure and a ceiling value of $13,179.60. The period of performance extends through May 12, 2025. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This is a $15,406.61 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the medication WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has an ultimate completion date of July 3, 2025. AmerisourceBergen Drug Corp holds a substantial Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of the prescription medication WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The firm-fixed-price contract has a ceiling value of $8,373.37 and a period of performance through May 19, 2025. The contract is not set aside and represents an open competition award. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- SPE2DB22D3019Indefinite Delivery Contract
- SPE2DB22D3019-SPE2DB25FK3XEDelivery Order
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of the medication WEGOVY 2.4 MG/0.75 ML PEN 0.75ML. The contract has a ceiling value of $8,324.40 and is a firm fixed-price delivery order contract, without any set-aside designation. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical support vehicle with a performance period extending through December 2026. This IDC enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.3k | 7/9/25 |